[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU42098A - Upotreba olanzapina - Google Patents

Upotreba olanzapina

Info

Publication number
YU42098A
YU42098A YU42098A YU42098A YU42098A YU 42098 A YU42098 A YU 42098A YU 42098 A YU42098 A YU 42098A YU 42098 A YU42098 A YU 42098A YU 42098 A YU42098 A YU 42098A
Authority
YU
Yugoslavia
Prior art keywords
olanzapine
interravan
preparation
treatment
distance
Prior art date
Application number
YU42098A
Other languages
English (en)
Inventor
Harlan Edgar Shannon
Daniel Edward Womer
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU42098A publication Critical patent/YU42098A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Opisana je upotreba olanzapina za pripremanje analgetske farmaceutske kompozicije pogodne kod tretiranja migrenoznog bola. Olanzapin koji se koristi za tu kompoziciju je polimorf Oblika II čije su difrakcije X-zraka kao što sledi, gde d predstavlja medjuravansko rastojanje: d d 10.2689 3.9873 8.577 3.7206 7.4721 3.5645 7.125 3.5366 6.1459 3.3828 6.071 3.2516 5.4849 3.134 5.2181 3.0848 5.1251 3.0638 4.9874 3.0111 4.7665 2.8739 4.7158 2.8102 4.4787 2.7217 4.3307 2.6432 4.2294 2.6007 4.141
YU42098A 1996-03-25 1998-09-25 Upotreba olanzapina YU42098A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1412796P 1996-03-25 1996-03-25

Publications (1)

Publication Number Publication Date
YU42098A true YU42098A (sh) 1999-09-27

Family

ID=21763694

Family Applications (1)

Application Number Title Priority Date Filing Date
YU42098A YU42098A (sh) 1996-03-25 1998-09-25 Upotreba olanzapina

Country Status (17)

Country Link
US (1) US5929070A (sh)
EP (1) EP0932407A4 (sh)
JP (1) JP2001508759A (sh)
KR (1) KR20000004966A (sh)
CN (1) CN1106196C (sh)
AU (1) AU721290B2 (sh)
BR (1) BR9708145A (sh)
CA (1) CA2250186A1 (sh)
CZ (1) CZ298398A3 (sh)
EA (1) EA000769B1 (sh)
IL (1) IL126063A (sh)
NO (1) NO984432L (sh)
NZ (1) NZ332037A (sh)
PL (1) PL329221A1 (sh)
UA (1) UA44838C2 (sh)
WO (1) WO1997035582A1 (sh)
YU (1) YU42098A (sh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258807B1 (en) * 1996-03-25 2001-07-10 Eli Lilly And Company Method for treating pain
UA48219C2 (uk) * 1996-03-25 2002-08-15 Елі Ліллі Енд Компані Композиція для вгамування болю (варіанти) та спосіб вгамування болю
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
CA2507158A1 (en) * 2002-11-26 2004-06-10 Alexza Molecular Delivery Corporation Treatment of headache with antipsychotics delivered by inhalation
JP2006514934A (ja) 2002-11-26 2006-05-18 アレックザ ファーマシューティカルズ， インコーポレイテッド 疼痛治療用薬剤製造のためのロキサピンまたはアモキサピンの使用
EP1625336B9 (en) 2003-05-21 2012-03-21 Alexza Pharmaceuticals, Inc. Use of a layer of solid fuel, method for producing such a layer and associated heating unit
WO2006027800A1 (en) * 2004-09-06 2006-03-16 Shasun Chemicals And Drugs Limited A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine
EP2121088B1 (en) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US11400048B2 (en) 2014-06-25 2022-08-02 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
JP6634034B2 (ja) 2014-06-25 2020-01-22 シネルジア・バイオ・サイエンシーズ・プライベイト・リミテッドＳｙｎｅｒｇｉａ Ｂｉｏ Ｓｃｉｅｎｃｅｓ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ 医薬水中油型ナノエマルジョン
WO2019152873A1 (en) 2018-02-02 2019-08-08 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
JPH06508352A (ja) * 1991-06-21 1994-09-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 門脈圧亢進症および片頭痛の治療用のテトラヒドロベンズアゼピン誘導体の使用
DK206591D0 (da) * 1991-12-23 1991-12-23 Lundbeck & Co As H Behandling af psykoser
NZ247703A (en) * 1992-05-29 1995-07-26 Lilly Industries Ltd Thienobenzdiazepine derivatives and medicaments thereof
CN1148340A (zh) * 1994-03-11 1997-04-23 伊莱利利公司 治疗与5htzb受体有关病症的方法
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
NO984432L (no) 1998-11-24
CZ298398A3 (cs) 1999-06-16
EP0932407A4 (en) 2002-04-24
IL126063A (en) 2002-04-21
CN1219876A (zh) 1999-06-16
EP0932407A1 (en) 1999-08-04
NZ332037A (en) 2001-01-26
BR9708145A (pt) 1999-07-27
AU2584597A (en) 1997-10-17
EA000769B1 (ru) 2000-04-24
CN1106196C (zh) 2003-04-23
IL126063A0 (en) 1999-05-09
WO1997035582A1 (en) 1997-10-02
AU721290B2 (en) 2000-06-29
EA199800864A1 (ru) 1999-02-25
JP2001508759A (ja) 2001-07-03
PL329221A1 (en) 1999-03-15
KR20000004966A (ko) 2000-01-25
UA44838C2 (uk) 2002-03-15
NO984432D0 (no) 1998-09-23
CA2250186A1 (en) 1997-10-02
US5929070A (en) 1999-07-27

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
ES2102367T3 (es) Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion.
ATE233274T1 (de) Oxyiminopregnancarbolactone
NO995810L (no) Nye forbindelser
ATE284690T1 (de) Antithrombotische diamine
ES2077199T3 (es) Nuevas piperacinas 1,4-disustituidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
YU42098A (sh) Upotreba olanzapina
DE60019334D1 (de) Antivirale arznei
SE9802208D0 (sv) Novel compounds
SE0102055D0 (sv) New Compounds
ES2221950T3 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
HUP0204318A2 (en) Torsemide polymorphic forms, process for their preparation, pharmaceutical compositions containing them and their use
BR9609847A (pt) Derivados de N-(4-Benzila-substituída)-2-aminolactam
IS1664B (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandiog kvalastillandi áhrif
ATE360428T1 (de) Analgetisches arzneimittel
NO980296L (no) Forbedrede terapeutiske midler
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
ATE400563T1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
SE9504662D0 (sv) New compounds
SE0004827D0 (sv) Therapeutic compounds
DE69828522D1 (de) Antithrombotische mittel
DE69431662D1 (de) Stabilisierte tablettenformulierung
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
ES2165509T3 (es) Composiciones terapeuticas efervescentes.